Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
Prolylhydroxylase inhibitors and methods of use
US9505741B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9505741-B2 |
| Application number | US-201113579646-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 17, 2011 |
| Priority date | Feb 17, 2010 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds for inhibiting hypoxia inducible factor (HIF) prolyl-4-hydroxylases (PHDs) having the general formula (1). Methods of using these and related compounds for treating a patient having a condition that would benefit from inhibiting HIF PHD are also described herein.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating a patient having brain ischemia, the method comprising administering to said patient in need thereof an effective amount of a HIF prolyl-4-hydroxylase inhibiting compound within the following general formula: wherein: R 1 is a monocyclic group, wherein said monocyclic group is optionally substituted with one or more groups…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9505741B2 cover?
- Compounds for inhibiting hypoxia inducible factor (HIF) prolyl-4-hydroxylases (PHDs) having the general formula (1). Methods of using these and related compounds for treating a patient having a condition that would benefit from inhibiting HIF PHD are also described herein.
- Who is the assignee on this patent?
- Ratan Rajiv R, Gazaryan Irina, Smirnova Natalya, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C07D401/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).